Buprenorphine

證據等級: L5

預測適應症: 6 個

---

目錄

1. Buprenorphine
2. Buprenorphine: Repurposing Candidate — No Prediction Data Available
   1. One-Sentence Summary
   2. Quick Overview
   3. Safety Considerations
   4. Conclusion and Next Steps
   5. Disclaimer

---

## 藥師評估報告

The txgnn-pipeline skill covers infrastructure/pipeline work, while this task is pure report generation as defined by the system prompt. I'll proceed directly with producing the Markdown report from the Evidence Pack.

---

Buprenorphine: Repurposing Candidate — No Prediction Data Available

One-Sentence Summary

Buprenorphine (DB00921) is a registered pharmaceutical compound, but this Evidence Pack contains no recorded original indications and no TxGNN-predicted new indications. Without a target indication, a formal drug repurposing assessment cannot be completed at this stage. Data remediation is required before evaluation can proceed.

---

Quick Overview

Item	Content
Original Indication	Not available
Predicted New Indication	No prediction generated
TxGNN Prediction Score	N/A
Evidence Level	N/A
Taiwan Market Status	Not marketed
Number of Authorizations	0
Recommended Decision	Hold

---

Safety Considerations

Please refer to the package insert for safety information.

---

Conclusion and Next Steps

Decision: Hold

Rationale: This Evidence Pack contains no TxGNN-predicted indications and no original indication data, making it impossible to conduct a repurposing assessment or evaluate mechanistic plausibility.

To proceed, the following is needed:

• TxGNN prediction output — predicted_indications is currently empty; the model must be re-run or results ingested for this candidate
• Original indication data — original_indications is empty; retrieve from TFDA or DrugBank approved indication fields
• Mechanism of action (MOA) — flagged as Data Gap (DG002, High severity); query DrugBank API (DB00921) to populate original_moa
• Safety data — key_warnings and contraindications are both flagged as Data Gap (DG001, Blocking severity); download and parse the TFDA package insert PDF to unblock S1 safety screening
• DDI data — drug–drug interaction query returned not_found; consider querying additional sources (e.g., DrugBank interactions endpoint, Lexicomp)

  Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.

---